DUBLIN--(BUSINESS WIRE)--The "Global Active Pharmaceutical Ingredient (API) Market with Focus on China & India: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

The global API market is forecasted to reach US$270.83 billion in 2024, growing at a CAGR of 6.5% for the period spanning 2020-2024. The factors such as increasing ageing population, rising healthcare expenditure per capita, growing cancer patients, inclining orphan drugs industry and accelerating outsourcing of API drugs are expected to drive the market. However, growth of the industry would be challenged by regulatory compliance. Few notable trends include growth in pharmaceutical R&D expenditures, growing artificial intelligence (AI) adoption for drug discovery, advancement in API synthesis and announcement of environmental protection policies on APIs by China.

In 2020, the outbreak of COVID-19 pandemic has created a favorable impact on the market as many nations have been continuously making micro-interventions, speeding up internal certification for third party sources and as well as ramping up domestic production to keep supply chains functional as best as can be done.

APIs are available in different types in the market. On the basis of available source, the categories include small molecule (chemical) and biological (large molecule).

The fastest growing regional market is China owing to abundance of capital and other resources, low material costs and wage rates along with relatively relax regulations.

Scope of the report:

• The report provides a comprehensive analysis of the global API market, segmented by synthesis (biological & small molecule) and manufacturers (captive & merchant).
• The major regional markets (China and India) have been analysed.
• The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Pfizer Inc., Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb Company and Teva Pharmaceutical Industries Limited) are also presented in detail.

Key Topics Covered:

1. Market Overview

1.1 Introduction

1.2 Classification of API

1.3 Manufacturers of API

1.4 Manufacturing Process of API

1.5 Supply Chain of API

2. Impact of COVID-19

2.1 Overview

2.2 Supply Assessment of Major APIs

2.3 China API Market

2.4 India API Market

3. Global API Market Analysis

4. Regional API Market Analysis

5. Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Ageing Population

5.1.2 Rising Healthcare Expenditure per Capita

5.1.3 Growing Cancer Patients

5.1.4 Inclining Orphan Drugs Industry

5.1.5 Accelerating Outsourcing of API Drugs

5.2 Key Trends and Developments

5.2.1 Growth in Pharmaceutical R&D Expenditures

5.2.2 Growing Artificial Intelligence (AI) Adoption for Drug Discovery

5.2.3 Advancement in API Synthesis

5.2.4 Announcement of Environmental Protection Policies on APIs by China

5.3 Challenges

5.3.1 Regulatory Compliance

6. Competitive Landscape

6.1 Global API Market

6.1.1 Key Players - Revenues Comparison

6.1.2 Key Players - Market Cap Comparison

6.1.3 Key Players - R&D Expenditures Comparison

6.2 China API Market

6.3 India API Market

7. Company Profiles

• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Roche Holding AG
• Teva Pharmaceutical Industries Limited

For more information about this report visit https://www.researchandmarkets.com/r/faha0c

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900